EQUITY RESEARCH MEMO

Antibody Solutions

Generated 5/10/2026

Executive Summary

Conviction (model self-assessment)65/100

Antibody Solutions is a privately held CRO headquartered in Sunnyvale, California, founded in 1994. The company specializes in custom antibody discovery and development, offering end-to-end services from antigen design through antibody manufacturing. Its fee-for-service model targets biopharmaceutical clients advancing diagnostics and therapeutics, emphasizing 'fit-for-purpose' antibodies. With over 25 years of domain expertise, Antibody Solutions has established a reputation for high-quality, tailored antibody solutions in a competitive CRO market.

Upcoming Catalysts (preview)

  • Q4 2026Potential partnership with a large pharmaceutical company for therapeutic antibody development40% success
  • Q3 2026Launch of a next-generation antibody discovery platform (e.g., phage display or single B cell technology)50% success
  • Q2 2027Expansion of manufacturing capacity to meet growing demand for preclinical antibody supply70% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)